Share Name Share Symbol Market Type Share ISIN Share Description
Physiomics Plc LSE:PYC London Ordinary Share GB00BDR6W943 ORD 0.4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.05 -1.72% 2.85 2.70 3.00 2.90 2.85 2.85 1,088,732 15:43:35
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 0.7 -0.2 -0.1 - 2

Physiomics Share Discussion Threads

Showing 27176 to 27199 of 27200 messages
Chat Pages: 1088  1087  1086  1085  1084  1083  1082  1081  1080  1079  1078  1077  Older
DateSubjectAuthorDiscuss
27/1/2020
17:23
Pol, Merck have to come back. If you understood what pyc does you'd know why. And to put it in perspective, Merck probably spend more a year on tea and coffee for their 65000 employees than they do with pyc..
davevt
26/1/2020
21:55
Rio tinto 100bn mkt cap Glencore 100bn mkt cap Spacedust mining 10k mkt cap Therefore spacedust mining will also fly based on the above
spacedust
24/1/2020
08:39
Thanks 'The Stigologist' for your posts & I believe that this is the year when PYC will have a share price rerate if only when we receive various financial updates but clearly at the current share price PYC is open for a takeover.
chrisatrdg
24/1/2020
01:40
They already talk on employee to employee basis. Longstanding links.
the stigologist
23/1/2020
16:12
Maybe they don't like their neighbours.
bobby.ifa
23/1/2020
10:24
Biotech M&A premia have been as high as 200-300% in the US SENS could easily offer PYC shareholders 10p a share and get this Company (which should be worth 50-100p anyway) on the cheap
the stigologist
23/1/2020
10:22
SENS have a massive 'Oncology' shaped hole in their AI offering...
the stigologist
23/1/2020
10:22
SENS £40m Cash PYC £2m They are neighbours on Oxford Science Park...
the stigologist
23/1/2020
09:44
Obviously they must be expecting share price to improve and understand they are in a land grab phase so it's 'eat or be eaten' ? I would point once again to ETX E-therapeutics Mkt Cap £10m PYC Physiomics Mkt Cap £2m which look crazily undervalued when Private UK Unicorns like Exscientia and BenevolentAI valued at $1000m+ (vs SENS at £60m Mkt with £40m cash) htTps://www.thetimes.co.uk/article/sensyne-health-on-the-acquisition-trail-to-halt-decline-in-share-price-jmfvbcw0q Sensyne Health on the acquisition trail to halt decline in share ... Sensyne Health said that it was “exploring a small number of strategic [mergers and acquisitions] opportunities that have the potential to scale our businessmore quickly to achieve a leadership position in the clinical artificial intelligence market and create value for shareholders”.
the stigologist
21/1/2020
11:42
Private UK Unicorns in AI biotech Benevolent AI £1 Billion + ExScientia $1 Billion + Publicly listed UK AI biotech comps RENX £200m+ SENS £60m+ ETX £10m PYC £2m PYC and ETX are on any measure massively undervalued
the stigologist
21/1/2020
10:19
Whats occurring ?
1corsair
21/1/2020
09:27
Oh hello. Maybe people understanding read-across from SENS ?
the stigologist
20/1/2020
14:04
If you say so.
on target
18/1/2020
17:35
HEMO is so early stage it's not worth anything At the moment it's a liability. Will be burning a lot of cash to build any 'value'.
the stigologist
18/1/2020
14:18
Yes, real junior pharma's with novel IP in this area such as HEMO might be snapped up this year. That could be made even more interesting by the insiders' 65% holding - they're not going to let it go without a fight.
on target
18/1/2020
11:13
Looking to build up its pipeline of future products, Eli Lilly (NYSE:LLY) aims to announce a $1B-5B deal for each quarter of 2020. • The acquisitions will focus largely on earlier stage opportunities across key therapeutic areas including oncology, pain, immunology, and neurology, quote from the CFO ! Note the immunology and oncology area, as I mentioned the hottest area in the Healthcare. They are joining a growing group of majors with “ have cash, will spend “.
the stigologist
17/1/2020
17:44
Nice to hear from C4X Am sure PYC had similar experience if they attended htTps://twitter.com/C4XDiscovery/status/1218216663394521089?s=20
the stigologist
17/1/2020
13:47
Texa - Oldest trick in the book .....lol Not that anyone should make investment decisions based BB banter. I do my own DD and its held me in good stead
optastic
15/1/2020
19:21
Iamgreat1 aka @thelongergame aka ZM19 on LSE Aka jammydodger (stopped posting on 6th December set up iamgreat1 on 6th December and ZM19 on LSE 8th December Deramps under one name pumps on other names
texaschaser
15/1/2020
16:01
The rampers have it a good go They tried to inflict the pain of this dog onto newbies by claiming last time it went to 30pNo one is fooled here and old stig is impaled like a muthaphooker
iamgreat1
15/1/2020
13:20
davevt, if you are correct why would Zahid Ali buy 3.5% of the company. based on his MO. I reckon he knows a hell of a lot more than you in this space. Also strange why Merck keeps coming back if its something drug companies do already. As I said...you have no idea what you are talking about
pol123
14/1/2020
15:01
Maybe news on the way. JP Morgan Healthcare Conference going on in the US alongside Biotech Showcase Physiomics partners Merck are GOLD Sponsors and Keynote Speakers Could be lots of very interesting deals and talks going on on sidelines
the stigologist
14/1/2020
11:46
Are you joking??? 😂 Pyc only do dose and frequency prediction for working cancer drugs in patient trials. I'll write that in layman's terms for you. The estimate how much of a drug to give a patient and how frequently, in a drug trial.. ...for cancer drugs only. No other drugs, just cancer drugs.. ..something drug companies do themselves already, obviously! How many working cancer drugs are made each year by all the drug companies. You could probably count it on one hand and have fingers left over. And then how many of those companies want or even need to use pyc? Pyc model is not Bio tech. It doesn't design or improve drugs, or discover drugs. It simply works on data to provide a best guess of an amount, no different to a paint company having to use a system to work out how much of what to make a colour. Their tech is SO old, their patents have actually expired 2 years ago. Yes, that's how old it is.
davevt
13/1/2020
21:25
davevt, you have no idea what you are talking about
pol123
Chat Pages: 1088  1087  1086  1085  1084  1083  1082  1081  1080  1079  1078  1077  Older
Your Recent History
LSE
PYC
Physiomics
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200127 19:38:45